Kevin Coveney
Director of Finance/CFO at ENVERIC BIOSCIENCES, INC.
Net worth: 5 963 $ as of 2024-04-29
Kevin Coveney active positions
Companies | Position | Start | End |
---|---|---|---|
ENVERIC BIOSCIENCES, INC. | Director of Finance/CFO | 2023-03-12 | - |
Career history of Kevin Coveney
Former positions of Kevin Coveney
Companies | Position | Start | End |
---|---|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Director of Finance/CFO | 2021-10-31 | 2022-05-31 |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2020-03-31 | 2021-03-31 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2018-10-31 | 2020-01-31 |
Director of Finance/CFO | 2018-10-31 | 2020-01-31 | |
Human Resources Officer | 2018-10-31 | 2020-01-31 | |
Braver PC
Braver PC Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Braver PC provides accounting services. The private company is based in Newton, MA. Braver was acquired by Marcum LLP, a SUB of Marcum Wealth LLC from The Braver Group on January 13, 2014. | Corporate Officer/Principal | 2007-06-30 | 2012-09-30 |
Training of Kevin Coveney
University of Massachusetts | Undergraduate Degree |
Statistics
International
United States | 7 |
Operational
Director of Finance/CFO | 5 |
Undergraduate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ENVERIC BIOSCIENCES, INC. | Health Technology |
Private companies | 4 |
---|---|
Braver PC
Braver PC Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Braver PC provides accounting services. The private company is based in Newton, MA. Braver was acquired by Marcum LLP, a SUB of Marcum Wealth LLC from The Braver Group on January 13, 2014. | Commercial Services |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kevin Coveney
- Experience